Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2025 – Nov 2025Where it's discussed
-
X / Twitter218 posts
-
News173 articles
-
Bluesky21 posts
-
Blogs15 articles
-
YouTube5 videos
-
Facebook5 posts
-
Reddit3 posts
AI synopsis
What people are saying
The overall tone captures excitement about the therapy's promise, with posts citing specific trial results like 83% insulin independence and references to high-profile research publications. Words like 'cure,' 'transformative,' and 'hope' reflect both optimism and active engagement in exploring the potential impact of these scientific advances.
Most discussions highlight the promising results and potential of the stem cell therapy, indicating strong support for the research conclusions.
The posts actively explore various aspects, including trial outcomes and future implications, demonstrating high curiosity about the developments.
Many discussions reference specific studies, clinical trials, and expert opinions, showing in-depth involvement.
The tone suggests that these advances could revolutionize diabetes treatment, implying a significant impact on medical practices and patient lives.
Abstract in brief
- The study evaluates the safety and effectiveness of zimislecel, a stem cell-derived therapy, in treating type 1 diabetes.
- Participants underwent infusions of either a half dose or full dose of zimislecel and received glucocorticoid-free immunosuppressive therapy.
- Results showed successful engraftment of islet cells in all 14 participants, though some serious adverse effects, including neutropenia and two deaths, were reported.
Top posts
Most liked on X and BlueskyNew in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) https://t.co/VBYUngj8GR Stem Cell–Derived Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https://t.co/4WOqQUIv3S Benzathine https://t.co/3uJ0UXj2Z1
4. Stem cell-derived islets for type 1 diabetes https://t.co/8ltiTPFTQV https://t.co/CKjOebAFiv
An incredible advance in regenerative medicine, reported in @NEJM this week: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | #helpisonthe way! https://t.co/QImh0qPf9A
10 of 12 #diabetes patients treated with stem cell–derived, fully differentiated Islets for Type 1 Diabetes remained free of insulin use at one yr. 3 cases of neutropenia. https://t.co/652dtVwUGF
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involving persons with type 1 diabetes support the hypothesis that zimislecel can restore physiologic islet function, warranting further clinical investigation https://t.co/Vl3ufTIOOI
All mentions
Stem Cell Therapy Shows Promise for Type 1 Diabetes Treatment
A stem cell-based infusion potentially cured 10 of 12 severe type 1 diabetes patients, with no need for insulin after one year. The study evaluates zimislecel, a stem cell-derived therapy, assessing safety and efficacy…
Advances in Stem Cell Therapy for Type 1 Diabetes Treatment
The study evaluates the safety and effectiveness of zimislecel, a stem cell-derived therapy, in treating type 1 diabetes. Participants underwent infusions of either a half dose or full dose of zimislecel and received…
Advancements in Stem Cell Therapy for Type 1 Diabetes Treatment
A clinical trial demonstrates that stem cell therapy can enable type 1 diabetes patients to produce their own insulin, reducing or eliminating daily injections. The therapy involves infusing cultured stem cell-derived…
Stem Cell Therapy Achieves Remission in Severe Type 1 Diabetes Patients
The VX880 study published in NEJM shows impressive results, with 83% of severe type 1 diabetes patients achieving insulin independence after a single infusion of stem cell-derived islets, highlighting a promising future…
Stem Cell-Based Fully Differentiated Islets for Type 1 Diabetes Treatment
This study evaluates the safety and effectiveness of zimislecel, a stem cell-derived therapy, in treating type 1 diabetes. Participants received infusions with immunosuppressive therapy; results showed successful…
RT @EricTopol: New @NEJM Pluripotent stem cells for Type 1 diabetes restored pancreatic islet cell function, improved glucose regulation, a…
https://t.co/3D12zNIQAy Ahora los científicos están aprendiendo a restaurar la fuente misma de la secreción de insulina, para devolver las partes que faltan.
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes is not in situ pancreas regeneration but cured type 1 diabetes in a small trial. https://t.co/IHJXFpiKiw
RT @HaoYin20: BTW, this paper is on @ResearchHub https://t.co/e40ABK567W Anyone interested in reviewing it, here are some relevant pubs…
BTW, this paper is on @ResearchHub https://t.co/e40ABK567W Anyone interested in reviewing it, here are some relevant pubs 1⃣Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes @VertexPharma VX-880-101 trial @NEJM 2025 https://t.co/Z58svYuzTR 2⃣Human assembloid https://t.co/UBiLVZLUIF
RT @EricTopol: New @NEJM Pluripotent stem cells for Type 1 diabetes restored pancreatic islet cell function, improved glucose regulation, a…
RT @SMCADMAN: 3/ Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes https://t.co/vVVCqvGokK
RT @SMCADMAN: 3/ Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes https://t.co/vVVCqvGokK
@princetongb $VRTX has Zimislecel as well that I haven’t read too much on yet. Sounded promising on my initial skim “Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes” on pubmed
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes https://t.co/59LMx8rn7N
RT @EricTopol: New @NEJM Pluripotent stem cells for Type 1 diabetes restored pancreatic islet cell function, improved glucose regulation, a…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/Pe3u9P9gzf
RT @omlakhani: Newer Updates in Type 1 Diabetes Management References: 1. Reichman TW, Markmann JF, Odorico J, Witkowski P, Fung JJ, Wi…
RT @ParrishLiz: https://t.co/a8gd76WM2d
Newer Updates in Type 1 Diabetes Management References: 1. Reichman TW, Markmann JF, Odorico J, Witkowski P, Fung JJ, Wijkstrom M, et al. Stem Cell--Derived, Fully Differentiated Islets for Type 1 Diabetes. N Engl J Med. 2025 Sep 4;393(9):858-68. DOI: 10.1056/NEJMoa2506549. 2
RT @ParrishLiz: https://t.co/a8gd76WM2d
Stem cell therapy zimislecel restored islet function in 83% of type 1 diabetes patients, achieving insulin independence and stable glucose control. by Reichman TW, Markmann JF (...) Rickels MR et 17 al. in N Engl J Med https://t.co/Bd0IXaFic2 #MedX #MedResearch
RT @CMichaelGibson: 10 of 12 #diabetes patients treated with stem cell–derived, fully differentiated Islets for Type 1 Diabetes remained fr…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/BeKf6gClGj
RT @Kottond: An incredible advance in regenerative medicine, reported in @NEJM this week: Stem Cell–Derived, Fully Differentiated Islets f…
https://t.co/a8gd76WM2d
RT @Kottond: An incredible advance in regenerative medicine, reported in @NEJM this week: Stem Cell–Derived, Fully Differentiated Islets f…
RT @Kottond: An incredible advance in regenerative medicine, reported in @NEJM this week: Stem Cell–Derived, Fully Differentiated Islets f…
RT @EricTopol: New @NEJM Pluripotent stem cells for Type 1 diabetes restored pancreatic islet cell function, improved glucose regulation, a…
RT @Kottond: An incredible advance in regenerative medicine, reported in @NEJM this week: Stem Cell–Derived, Fully Differentiated Islets f…
RT @Kottond: An incredible advance in regenerative medicine, reported in @NEJM this week: Stem Cell–Derived, Fully Differentiated Islets f…
An incredible advance in regenerative medicine, published this week: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | NEJM: www.nejm.org/doi/full/10....
An incredible advance in regenerative medicine, reported in @NEJM this week: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | #helpisonthe way! https://t.co/QImh0qPf9A
RT @EARL_med_tw:
RT @EARL_med_tw:
RT @EARL_med_tw:
RT @UPENN_ITMAT: Allogeneic #StemCell -derived islet- #CellTherapy as a candidate to restore physiologic #IsletFunction https://t.co/qTci3R…
RT @EARL_med_tw:
RT @NEJM: Zimislecel is an allogeneic stem cell–derived islet-cell therapy. The VX-880-101 FORWARD phase 1–2 study supports the hypothesis…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/JFObkh8HSV
RT @NEJM: Zimislecel is an allogeneic stem cell–derived islet-cell therapy. The VX-880-101 FORWARD phase 1–2 study supports the hypothesis…
RT @NEJM: Zimislecel is an allogeneic stem cell–derived islet-cell therapy. The VX-880-101 FORWARD phase 1–2 study supports the hypothesis…
RT @NEJM: Zimislecel is an allogeneic stem cell–derived islet-cell therapy. The VX-880-101 FORWARD phase 1–2 study supports the hypothesis…
RT @NEJM: Zimislecel is an allogeneic stem cell–derived islet-cell therapy. The VX-880-101 FORWARD phase 1–2 study supports the hypothesis…
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. The VX-880-101 FORWARD phase 1–2 study supports the hypothesis that zimislecel can restore physiologic islet function and thus treat persons with type 1 diabetes. Full study results: https://t.co/4WOqQUIv3S https://t.co/8SbiPo80vy
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
Hope for type I #diabetes patients. https://t.co/aFkwJezvNy
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
Allogeneic #StemCell -derived islet- #CellTherapy as a candidate to restore physiologic #IsletFunction https://t.co/qTci3RFbnV #DiabetesResearch #Diabetes #T1D #IsletBiology #TranslationalScience
Great news and a highly anticipated article. Not a word about the immunosuppression received??? Just a mention in supplemental material (standard steroid-free IS, islet transplantation protocol by the Clinical Islet Transplantation Consortium). https://t.co/sPAbDsEgx4
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/yGkcuLcMSL
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
RT @NEJM: New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) htt…
New in the September 4, 2025, issue of NEJM: Maridebart Cafraglutide for the Treatment of Obesity (MariTide phase 2 trial) https://t.co/VBYUngj8GR Stem Cell–Derived Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https://t.co/4WOqQUIv3S Benzathine https://t.co/3uJ0UXj2Z1
RT @SMCADMAN: 3/ Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes https://t.co/vVVCqvGokK
RT @DrGunerSonmez: İyi ki bilim var ❤️ İyi ki bilim insanları var ❤️ https://t.co/UivFYo9hYT https://t.co/cOo5ktoRMx
RT @suzuki_takaya: ついにここまできた幹細胞治療の第3相試験。 胚性幹細胞(ES細胞)由来のベータ細胞の投与で1型糖尿病患者12人中10人が投与1年でインスリンフリーに。このES細胞は他人由来なので免疫抑制剤を併用しています。 https://t.co/gtF…
@DGlaucomflecken A cure for diabetes is coming in the next few years from this technology https://t.co/n9fInckcZe
Scientists Cure First Type 1 Diabetes Patients https://t.co/dN6XZuGfJa via @YouTube
https://t.co/MQDqTXKWG0
Stem cells hold promise as a cure for type 1 Diabetes https://t.co/7dXTFinWe8 https://t.co/i7WfHB7REa
Scientists Cure First Type 1 Diabetes Patients https://t.co/Dk4P0yDso2 via @YouTube
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/kTJyDK4MWa
https://t.co/eHuz4XSMWT
Scientists Cure First Type 1 Diabetes Patients https://t.co/W8VAmoLKp7 via @YouTube
RT @UPENN_ITMAT: Exploring the potential to restore physiologic islet function through fully differ¬entiated, allogeneic pluripotent stem c…
RT @DrGunerSonmez: İyi ki bilim var ❤️ İyi ki bilim insanları var ❤️ https://t.co/UivFYo9hYT https://t.co/cOo5ktoRMx
@Fearthecow93 @oncloud_e @JennaLynnMeowri jfc the US has multiple university research teams as well as huge companies working on this - it would be an instant Nobel Prize and a license to print money, it’s not being suppressed https://t.co/66pkYSpeE5
@DrNeilStone Type 1 diabetes may be curable: Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes - PubMed https://t.co/cyZnvBLviu
RT @DrMarcSiegel: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine was great to intervi…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine was great to interview lead author Trevor Reichman MD on @NYUDocs @nyulangone at 2 PM yesterday on this amazing transplant https://t.co/5E0iKhGXhz
Stem Cell–Derived, Fully Differentiated #Islets for #T1DM @NEJM https://t.co/5vX0b9hYSi
RT @JeffreyRMillman: Big #T1D news! Vertex has published their phase 1–2 trial of stem cell-derived islets (VX880, now called zimislecel).…
Stem-cell–derived islets may become a scalable cure for T1D. Still early days—but if these results hold in Phase 3, this will be a landmark in regenerative medicine. Not managing diabetes—ending it.
RT @JeffreyRMillman: Big #T1D news! Vertex has published their phase 1–2 trial of stem cell-derived islets (VX880, now called zimislecel).…
https://t.co/5FSubKx9fR
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine They "conducted a phase 1–2 study of zimislecel in persons with type 1 diabetes." www.nejm.org/doi/full/10....
Type 1 diabetes is often the result of a viral infection. Treatments are on the horizon. Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine www.nejm.org/doi/full/10....
Here's the kind of thing that makes me love science and technology. https://t.co/J7esc9jLCa
Allogenic stem cell–derived islet-cell therapy for type 1 diabetes #T1D #diabetology #endocrinology https://t.co/ySB2BL9Ged
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/EoU0zywCcT
@hobbs_joe34741 @DrNeilStone It is not officially reversible, yet. But until very recently, it was really not reversible. https://t.co/Z4ft2ZRfKz
@DrNeilStone Not yet... (But through no fault of CHD.) https://t.co/Z4ft2ZRfKz
https://t.co/EWlEjBZvHz
RT @_jdevos_:
RT @_jdevos_:
RT @_jdevos_:
RT @_jdevos_:
الخلايا الجذعية /داء السكري من النوع الأول. العلاج الجديد لهذا المرض. https://t.co/3dkHLkaJlk الخلايا الجذعية Pluripotent stem cells المحفزة المتعددة القدرات لمرض السكري من النوع الأول استعادت وظيفة خلايا البنكرياس الجزيرية وحسّنت تنظيم الجلوكوز glucose وقللت الحاجة إلى
RT @KiaNeu6: This singe injection diabetes treatment will free people from insulin injections https://t.co/4joBO0JKNV
This singe injection diabetes treatment will free people from insulin injections https://t.co/4joBO0JKNV
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes https://t.co/qkb4pMzSCl?
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes https://t.co/GoBNLJlTYb?
Scientists Cure First Type 1 Diabetes Patients https://t.co/JKhTkXUWIp via @YouTube
https://t.co/BCIrAJUriM
RT @PennMedCSO: A new study out in @NEJM supports the hypothesis that zimislecel can restore physiologic islet function in persons with typ…
RT @drbennisahmed: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involvin…
RT @drbennisahmed: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involvin…
RT @drbennisahmed: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involvin…
RT @PennMedCSO: A new study out in @NEJM supports the hypothesis that zimislecel can restore physiologic islet function in persons with typ…
RT @drbennisahmed: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involvin…
A new study out in @NEJM supports the hypothesis that zimislecel can restore physiologic islet function in persons with type 1 diabetes ft. Michael Rickels (@PennIDOM/ @PennEndocrine) & James Markmann (@PennSurgery) https://t.co/UCaFaGv694 https://t.co/Qf3Ccw97IU
https://t.co/LuUEHBKHbB
RT @drbennisahmed: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involvin…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involving persons with type 1 diabetes support the hypothesis that zimislecel can restore physiologic islet function, warranting further clinical investigation https://t.co/Vl3ufTIOOI
Scientists Cure First Type 1 Diabetes Patients https://t.co/MSeJKM5pPd via @YouTube
https://t.co/HOk9NQwACP
Scientists Cure First Type 1 Diabetes Patients https://t.co/65E63KUqQS via @YouTube
Scientists Cure Type 1 Diabetes in First Patients https://t.co/42jircPz7D
▶️ Zimislecel ( terapia alogénica de islotes derivados de células madre ) ✅ Estudio de fase 1-2 ▶️ zimislecel puede restaurar la función fisiológica de los islotes páncreas
Warning: the following article contains Scientific Facts & hopeful news Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabeteshttps://www.nejm.org/doi/full/10.1056/NEJMoa2506549
RT @DrSamuelBHume: 4. Stem cell-derived islets for type 1 diabetes https://t.co/8ltiTPFTQV https://t.co/CKjOebAFiv
RT @DrSamuelBHume: 4. Stem cell-derived islets for type 1 diabetes https://t.co/8ltiTPFTQV https://t.co/CKjOebAFiv
RT @CMichaelGibson: 10 of 12 #diabetes patients treated with stem cell–derived, fully differentiated Islets for Type 1 Diabetes remained fr…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/eJB2vnHOfT
RT @DrSamuelBHume: 4. Stem cell-derived islets for type 1 diabetes https://t.co/8ltiTPFTQV https://t.co/CKjOebAFiv
4. Stem cell-derived islets for type 1 diabetes https://t.co/8ltiTPFTQV https://t.co/CKjOebAFiv
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/uaNA0UjORs
@stgoldst @BiotechMongoose Stem cell transplants did so well in a type-1 diabetes trial that the company had to release the results early. https://t.co/tjVYX8vQGM
RT @CMichaelGibson: 10 of 12 #diabetes patients treated with stem cell–derived, fully differentiated Islets for Type 1 Diabetes remained fr…
RT @CMichaelGibson: 10 of 12 #diabetes patients treated with stem cell–derived, fully differentiated Islets for Type 1 Diabetes remained fr…
RT @CMichaelGibson: 10 of 12 #diabetes patients treated with stem cell–derived, fully differentiated Islets for Type 1 Diabetes remained fr…
RT @CMichaelGibson: 10 of 12 #diabetes patients treated with stem cell–derived, fully differentiated Islets for Type 1 Diabetes remained fr…
RT @CMichaelGibson: 10 of 12 #diabetes patients treated with stem cell–derived, fully differentiated Islets for Type 1 Diabetes remained fr…
RT @CMichaelGibson: 10 of 12 #diabetes patients treated with stem cell–derived, fully differentiated Islets for Type 1 Diabetes remained fr…
10 of 12 #diabetes patients treated with stem cell–derived, fully differentiated Islets for Type 1 Diabetes remained free of insulin use at one yr. 3 cases of neutropenia. https://t.co/652dtVwUGF
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/jjZ1x0FEZM
A woman with type 1 diabetes is now insulin-free after just a single stem cell implant. More: https://t.co/1b1gN3S7ZN #BREAKING #diabetes #InsulinResistance https://t.co/oRg7z0uspa
Islotes totalmente diferenciados derivados de células madre para la diabetes tipo 1 | New England Journal of Medicine https://t.co/gjfwGeEpCb
Islotes totalmente diferenciados derivados de células madre para la diabetes tipo 1 | New England Journal of Medicine https://t.co/gjfwGeEXrJ
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/l7pC5doTWE
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/59f8zm6o0b Un poco de ciencia sobre células madre y tratamiento de Diabetes Mellitus tipo 1
RT @ramosmd: ¿La cura de la #diabetes tipo 1? Zimislecel (islotes derivados de células madre) restauro la función de c. beta, elimino even…
RT @ramosmd: ¿La cura de la #diabetes tipo 1? Zimislecel (islotes derivados de células madre) restauro la función de c. beta, elimino even…
Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes Trevor W Reichman et al. N Engl J Med. 2025. https://t.co/ZUbQ0Cmdpb
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes https://t.co/ZdPj5LAZ7Z
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes www.nejm.org/doi/full/10....
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/YIMsxN7S2p
Vertex just cured 10/12 type 1 diabetics with stem cells #stemcells #t1d https://t.co/wKImCbjrbY
Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes - PubMed https://t.co/x3lp3AUxNm
RT @since1795: @KirillPol2 https://t.co/n2zCFHG46j
RT @sakrustots: https://t.co/pamVq08pDC
https://t.co/SEidXOOGgL
RT @SMCADMAN: 3/ Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes https://t.co/vVVCqvGokK
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine www.nejm.org/doi/full/10....
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/DJJC19jY25
A small study suggests that zimislecel, an experimental therapy for type 1 diabetes, may restore islet cell function, allowing some participants to remain insulin independent. However, safety concerns need further investigation. - Read more: https://t.co/DuoC5649h4
@KirillPol2 https://t.co/n2zCFHG46j
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/60dr5kC8eD
To byłaby duża sprawa. Jeśli się przeskakuje. Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/hfOQIMwOFV
https://t.co/pamVq08pDC
This stem cell-based therapy offers a potentially transformative approach to restoring insulin production and reducing dependence on daily injections. https://t.co/NX5xH3BSJw
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine www.nejm.org/doi/full/10.... 83% had insulin independence and were not using exogenous insulin at day 365
"Stem-cell treatment cures diabetes" No longer science fiction!
RT @GlobalPHObserv: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/bUnsD…
RT @GlobalPHObserv: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/bUnsD…
RT @GlobalPHObserv: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/bUnsD…
RT @GlobalPHObserv: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/bUnsD…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/bUnsDkIP2u
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/DLXgFdxoLk
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes https://t.co/tY9mTnxA2B
Collaborators, including Dr. Trevor Reichman from @UHN, show that zimislecel, an allogeneic stem cell–derived islet-cell therapy, can restore physiologic #islet function.
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/zvC9m3ITUr
RT @AusStemCell: ‘New Treatment May Cure Severe Type 1 Diabetes, Study Finds’ – results of a small, two-phase clinical trial of stem cell t…
Exploring the potential to restore physiologic islet function through fully differ¬entiated, allogeneic pluripotent stem cell–derived islet-cell therapy for #Type1Diabetes https://t.co/qTci3RFJdt #StemCell #CellTherapy #TranslationalScience
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes #science #publication #research #journal https://t.co/IClMl00cHx
RT @AusStemCell: ‘New Treatment May Cure Severe Type 1 Diabetes, Study Finds’ – results of a small, two-phase clinical trial of stem cell t…
3/ Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes https://t.co/vVVCqvGokK
RT @AusStemCell: ‘New Treatment May Cure Severe Type 1 Diabetes, Study Finds’ – results of a small, two-phase clinical trial of stem cell t…
RT @AusStemCell: ‘New Treatment May Cure Severe Type 1 Diabetes, Study Finds’ – results of a small, two-phase clinical trial of stem cell t…
‘New Treatment May Cure Severe Type 1 Diabetes, Study Finds’ – results of a small, two-phase clinical trial of stem cell therapy developed by Boston-based @VertexPharma [Paper - https://t.co/DbGXbrddn6]: https://t.co/jzE8IS8Pmu @UofT
RT @GlobalPHObserv: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/bUnsD…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/AkFEDc2DTf
@RedKingRuairi1 Possible new treatment to cure Type 1 Diabetes.Great News.
RT @GlobalPHObserv: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/bUnsD…
RT @GlobalPHObserv: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/bUnsD…
RT @ESodicoffMD:
"¿Un antes y un después en la #diabetes tipo1? #clinicaltrials #clinicalresearch #Zimislecel https://t.co/huWJFEXEUO via @YouTube
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/bUnsDkIP2u
RT @drbennisahmed: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involvin…
RT @anishmohammed: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/ZdivKW…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/ZdivKWW1c8 < looks promising for Type 1 patients
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes #science #publication #research #publications https://t.co/TenfhOtuzq
RT @drbennisahmed: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involvin…
RT @drbennisahmed: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involvin…
RT @drbennisahmed: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involvin…
RT @drbennisahmed: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involvin…
Avance esperanzador. Diez pacientes con diabetes tipo 1 severa no necesitan inyectarse insulina un año después de una sola infusión de células madre (hilo) Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/SFbNlw7LwI
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes The results of this small, short-term study involving persons with type 1 diabetes support the hypothesis that zimislecel can restore physiologic islet function https://t.co/0adwU0meja https://t.co/BEmRF0Vi4i
10 out of 12 people cured in Type 1 Diabetes Study https://www.nejm.org/doi/full/10.1056/NEJMoa2506549 (https://news.ycombinator.com/item?id=44351341)
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
10 out of 12 people cured in Type 1 Diabetes Study https://www.nejm.org/doi/full/10.1056/NEJMoa2506549 (https://news.ycombinator.com/item?id=44351341)
10 out of 12 people cured in Type 1 Diabetes Study https://www.nejm.org/doi/full/10.1056/NEJMoa2506549
10 out of 12 people cured in Type 1 Diabetes Study https://t.co/hw5YMk0v85 Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
10 out of 12 people cured in Type 1 Diabetes Study L: https://www.nejm.org/doi/full/10.1056/NEJMoa2506549 C: https://news.ycombinator.com/item?id=44351341 posted on 2025.06.22 at 20:17:24 (c=2, p=5)
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @giorg_kyriakos:
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
www.nejm.org/doi/full/10.... Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes!
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/JFObkh8HSV
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/EEW0g1OOsh
RT @bradwouters: Exciting new clinical progress in stem cell derived therapies @UHN @UHNTransplant Stem Cell–Derived, Fully Differenti…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @bradwouters: Exciting new clinical progress in stem cell derived therapies @UHN @UHNTransplant Stem Cell–Derived, Fully Differenti…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
RT @KSusztak: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | @NEJM lead by @PennIDOM Mike Rickells @VertexPharma…
RT @NEJM: Original Article: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (VX-880-101 FORWARD phase 1–2 study) https:/…
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes. #NEJM "zimislecel can restore physiologic islet function" Reference www.nejm.org/doi/full/10....
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine www.nejm.org/doi/full/10....
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine www.nejm.org/doi/full/10....
A potentially major advance in the treatment of Type 1 Diabetes pioneered by Vertex and led by Dr. Mike Rickels of @Penn Medicine. Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine www.nejm.org/doi/full/10....
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine www.nejm.org/doi/full/10....
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes: a cure in sight? | New England Journal of Medicine
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes www.nejm.org/doi/full/10....
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine www.nejm.org/doi/full/10.... Hope this proves as transformative as the Edmonton Protocol
Z
AA
I
HY
AL
S
S
AF
AL
ク
EM